Luckson Mathieu

920 total citations
12 papers, 526 citations indexed

About

Luckson Mathieu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Luckson Mathieu has authored 12 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Luckson Mathieu's work include Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Luckson Mathieu is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Luckson Mathieu collaborates with scholars based in United States and France. Luckson Mathieu's co-authors include Richard Pazdur, Erin Larkins, Kirsten B. Goldberg, Charles M. Rudin, Norma Kanarek, Malcolm V. Brock, Lisa Rodríguez, Gideon M. Blumenthal, Hai-Lung Tsai and Patricia Keegan and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The American Journal of Medicine.

In The Last Decade

Luckson Mathieu

12 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luckson Mathieu United States	8	290	254	157	87	75	12	526
Daniele Lavacchi Italy	12	303 1.0×	184 0.7×	124 0.8×	75 0.9×	85 1.1×	46	476
Tahsin M. Khan United States	8	344 1.2×	364 1.4×	275 1.8×	51 0.6×	115 1.5×	23	604
Fangfang Lü China	3	238 0.8×	217 0.9×	151 1.0×	55 0.6×	85 1.1×	4	458
Shinji Nakamichi Japan	13	281 1.0×	268 1.1×	238 1.5×	44 0.5×	88 1.2×	51	566
Andrea Ravelli Italy	10	288 1.0×	251 1.0×	200 1.3×	36 0.4×	106 1.4×	15	543
Giacomo Bregni Italy	12	291 1.0×	141 0.6×	110 0.7×	97 1.1×	81 1.1×	43	443
Amy Prawira Canada	11	326 1.1×	147 0.6×	172 1.1×	62 0.7×	111 1.5×	38	621
Fabiana Napolitano Italy	12	220 0.8×	172 0.7×	144 0.9×	104 1.2×	94 1.3×	31	448
Naoki Furuya Japan	16	510 1.8×	590 2.3×	181 1.2×	72 0.8×	126 1.7×	89	827
Lingzhi Hong United States	12	216 0.7×	238 0.9×	213 1.4×	45 0.5×	115 1.5×	28	487

Countries citing papers authored by Luckson Mathieu

Since Specialization

Citations

This map shows the geographic impact of Luckson Mathieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luckson Mathieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luckson Mathieu more than expected).

Fields of papers citing papers by Luckson Mathieu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luckson Mathieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luckson Mathieu. The network helps show where Luckson Mathieu may publish in the future.

Co-authorship network of co-authors of Luckson Mathieu

This figure shows the co-authorship network connecting the top 25 collaborators of Luckson Mathieu. A scholar is included among the top collaborators of Luckson Mathieu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luckson Mathieu. Luckson Mathieu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Barnetche, Thomas, S. Prey, Caroline Dutriaux, et al.. (2024). Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study. Joint Bone Spine. 92(1). 105795–105795. 1 indexed citations

Mathieu, Luckson, Erin Larkins, A. K. Sinha, et al.. (2023). FDA Approval Summary: Atezolizumab as Adjuvant Treatment following Surgical Resection and Platinum-Based Chemotherapy for Stage II to IIIA NSCLC. Clinical Cancer Research. 29(16). 2973–2978. 27 indexed citations

Akinboro, Oladimeji, Jonathon Vallejo, Erica C. Nakajima, et al.. (2022). Outcomes of anti–PD-(L)1 therapy with or without chemotherapy (chemo) for first-line (1L) treatment of advanced non–small cell lung cancer (NSCLC) with PD-L1 score ≥ 50%: FDA pooled analysis.. Journal of Clinical Oncology. 40(16_suppl). 9000–9000. 37 indexed citations

Mathieu, Luckson, Sujay Shah, Lee H. Pai-Scherf, et al.. (2021). FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer. The Oncologist. 26(5). 433–438. 102 indexed citations

Nakajima, Erica C., Marcus Messmer, Jennifer M. Jones, et al.. (2021). Hematology/medical oncology fellow responses to the initial development of an antiracism curriculum.. Journal of Clinical Oncology. 39(15_suppl). 11042–11042. 2 indexed citations

Chang, Elaine, Yutao Gong, Jonathon Vallejo, et al.. (2019). FDA analysis of outcomes in Asian patients (pts) with metastatic non-small cell lung cancer (mNSCLC) receiving immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 37(15_suppl). e20690–e20690. 11 indexed citations

Odogwu, Lauretta, Luckson Mathieu, Gideon M. Blumenthal, et al.. (2018). FDA Approval Summary: Dabrafenib and Trametinib for the Treatment of Metastatic Non-Small Cell Lung Cancers Harboring BRAF V600E Mutations. The Oncologist. 23(6). 740–745. 166 indexed citations

Odogwu, Lauretta, Luckson Mathieu, Kirsten B. Goldberg, et al.. (2017). FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation. The Oncologist. 23(3). 353–359. 49 indexed citations

Kanarek, Norma, Craig M. Hooker, Luckson Mathieu, et al.. (2014). Survival After Community Diagnosis of Early-stage Non-small Cell Lung Cancer. The American Journal of Medicine. 127(5). 443–449. 48 indexed citations

10.

Mathieu, Luckson, Norma Kanarek, Hai-Lung Tsai, Charles M. Rudin, & Malcolm V. Brock. (2013). Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). Diseases of the Esophagus. 27(8). 757–763. 78 indexed citations

11.

Mathieu, Luckson, Craig M. Hooker, Norma Kanarek, Charles M. Rudin, & Malcolm V. Brock. (2012). Esophageal cancer incidence gender disparity.. Journal of Clinical Oncology. 30(15_suppl). 1573–1573. 1 indexed citations

12.

Mathieu, Luckson, Norma Kanarek, Craig M. Hooker, Charles M. Rudin, & Malcolm V. Brock. (2012). Esophageal cancer gender disparity.. Journal of Clinical Oncology. 30(30_suppl). 47–47. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact